Skip to main content
Clinical Trials/IRCT20230612058465N1
IRCT20230612058465N1
Not yet recruiting
Phase 3

Comparison of the effectiveness and side effects of ketamine and haloperidol in controlling acute delirium and acute agitation

Mashhad University of Medical Sciences0 sites120 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Acute agitation.
Sponsor
Mashhad University of Medical Sciences
Enrollment
120
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • All acutely agitated patients enrolled in the study. Treatable causes such as hypoxia and hypoglycemia were evaluated in if present, treated.

Exclusion Criteria

  • Any sensitivity to ketamine or haloperidol, past medical history of dissection or myocardial infarction, or QT prolongation lead to exclude from the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials